Ani Pharmaceuticals (ANIP) Enterprise Value Growth (5y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -71.53% |
| Mar 31, 2026 | -65.49% |
| Dec 31, 2025 | -85.89% |
| Sep 30, 2025 | -71.12% |
| Jun 30, 2025 | -51.05% |
| Mar 31, 2025 | -48.98% |
| Dec 31, 2024 | -18.38% |
| Sep 30, 2024 | -19.43% |
| Jun 30, 2024 | -42.69% |
| Mar 31, 2024 | -43.00% |
| Dec 31, 2023 | -38.74% |
| Sep 30, 2023 | -34.33% |
| Jun 30, 2023 | -24.07% |
| Mar 31, 2023 | -5.45% |
| Dec 31, 2022 | -11.32% |
| Sep 30, 2022 | -27.72% |
| Jun 30, 2022 | -52.22% |
| Mar 31, 2022 | -49.89% |
| Dec 31, 2021 | -30.93% |
| Sep 30, 2021 | 1.14% |